Tirzepatide Weight Loss: The New Fat-Burning Breakthrough

Tirzepatide is a 39 amino acid synthetic peptide with dual agonist activity at GIP and GLP-1 receptors. It targets impaired insulin production and action in type 2 diabetes.

But keep in mind that Tirzepatide is only FDA-approved for treating type 2 diabetes mellitus. It is not approved for treating type-1 diabetes mellitus.

It can be used off-label for treating obesity. Tirzepatide is currently implemented as a second-line diabetes medication. Tirzepatide exhibited superior effects compared to the selective GLP-1 receptor agonist dulaglutide.Tirzepatide is a 39 amino acid synthetic peptide with dual agonist activity at GIP and GLP-1 receptors. It targets impaired insulin production and action in type 2 diabetes.

But keep in mind that Tirzepatide is only FDA-approved for treating type 2 diabetes mellitus. It is not approved for treating type-1 diabetes mellitus.

It can be used off-label for treating obesity. Tirzepatide is currently implemented as a second-line diabetes medication. Tirzepatide exhibited superior effects compared to the selective GLP-1 receptor agonist dulaglutide.